Bluenote AI key facts
- Developer of a life sciences AI Platform designed to accelerate innovation with AI and improve document quality.
- It has raised $10.0M; the latest was Early Stage VC ($10.0M) in Dec 2024.
- Notable investors include Lux Capital, Menlo Ventures, Elad Gil, Electric Capital, Qasar Younis — 15 tracked in total.
- Status: Privately Held (backing).
Who backs Bluenote AI
15+Membership and data by Private Market View
- ·The complete investor list: 15 names
- ·Watch Bluenote AI: the Monday email on marks, rounds and moves
Bluenote AI funding rounds
No funding rounds for Bluenote AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Bluenote AI investors
15 investors are on record for Bluenote AI, including Lux Capital, Menlo Ventures, Elad Gil and Electric Capital. By type, the record holds 3 venture capital firms, 2 angel investors and 1 private investor.
About Bluenote AI
Developer of a life sciences AI Platform designed to accelerate innovation with AI and improve document quality. The company's platform is built for and trusted by leading life sciences companies, enabling customers to automate copy-pasting and synthesis tasks and improve document quality for CSRs, CMC documents, AV reports, ICFs, and more.
- Sector
- Information Technology
- HQ
- San Francisco, CA, United States
- Founded
- 2022
- Employees
- 14
- Website
- bluenote.ai/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Bluenote AI doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.